We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

BioProgress Starts Patent Action Against Stanelco

Law360 (October 22, 2003, 12:00 AM EDT) -- BioProgress Technology Limited, a wholly owned subsidiary of U.K. medical capsule maker BioProgress plc, Tuesday commenced proceedings against Stanelco Fibre Optics Limited, over "key" patents and patent applications, BioProgress said in a statement.

The case concerns patents for processes for encapsulation by gelatin-free polymeric materials, invented by BioProgress Technology Limited in 1998, according BioProgress. BioProgress has asked the court to issue an order to have BioProgress registered as the rightful owner of the patents and patent applications in question.

Under its generic brand XGelTM, BioProgress has...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.